The U.S. Supreme Court will hear oral arguments Monday in Harrington v. Purdue Pharma to determine whether a bankruptcy court can discharge claims against a party that did not itself file for bankruptcy.
In 2019, Purdue Pharma was mired in thousands of lawsuits across the country with business partners, states, hospitals, and victims of opioid addiction and their family members due to the company’s production and marketing of OxyContin, a controlled substance prescribed for managing pain.
Nick Hafen is the head of legal technology education at BYU Law.
